Steven Kao

8.1k total citations · 1 hit paper
103 papers, 3.7k citations indexed

About

Steven Kao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Steven Kao has authored 103 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Steven Kao's work include Occupational and environmental lung diseases (48 papers), Lung Cancer Treatments and Mutations (26 papers) and Pleural and Pulmonary Diseases (26 papers). Steven Kao is often cited by papers focused on Occupational and environmental lung diseases (48 papers), Lung Cancer Treatments and Mutations (26 papers) and Pleural and Pulmonary Diseases (26 papers). Steven Kao collaborates with scholars based in Australia, United States and Japan. Steven Kao's co-authors include Nico van Zandwijk, Glen Reid, Stephen Clarke, Michael Boyer, Nick Pavlakis, Michaela B. Kirschner, Wendy A. Cooper, Nicola J. Armstrong, J. James Edelman and Michael P. Vallely and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Steven Kao

102 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer

2019 269 citations Benjamin Solomon, Steven Kao et al. profile →

Peers

Steven Kao

PRM

ONCOL

IMMUN

Keisuke Aoe Japan

Aurélie Cazes France

Bo Dai China

Qi Xue China

Hisao Imai Japan

Veronica Mollica Italy

Kathryn A. Gold United States

Thomas Brodowicz Austria

Kosei Maemura Japan

Simon Thézenas France

Keisuke Aoe Japan

Steven Kao

2.1k ×1.1

PRM

1.5k ×0.9

ONCOL

872 ×0.7

587 ×0.5

292 ×0.7

IMMUN

Citations per year, relative to Steven Kao Steven Kao (= 1×) peers Keisuke Aoe

Countries citing papers authored by Steven Kao

Since Specialization

Citations

This map shows the geographic impact of Steven Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Kao more than expected).

Fields of papers citing papers by Steven Kao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Kao. The network helps show where Steven Kao may publish in the future.

Co-authorship network of co-authors of Steven Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Kao. A scholar is included among the top collaborators of Steven Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Kao. Steven Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kao, Steven, et al.. (2025). Psoriasis and risk of diabetic retinopathy in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 229. 112912–112912.

Alexander, Marliese, Sagun Parakh, Paul Mitchell, et al.. (2024). Lurbinectedin in small cell lung cancer: real‐world experience of a multicentre national early access programme. Australasian Journal of Paramedicine. 54(7). 1087–1096. 5 indexed citations

Linton, Anthony, Steven Kao, Sonja Klebe, et al.. (2023). High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma. Histopathology. 83(2). 202–210. 8 indexed citations

Ahmadzada, Tamkin, Fatemeh Vafaee, Glen Reid, et al.. (2023). Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential. Cancers. 15(8). 2364–2364. 8 indexed citations

Lee, Jessica, et al.. (2022). Dying of mesothelioma: A qualitative exploration of caregiver experiences. European Journal of Cancer Care. 31(5). e13627–e13627. 3 indexed citations

Kao, Steven, et al.. (2022). An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma. SHILAP Revista de lepidopterología. 20 indexed citations

Yap, Timothy A., Kazuhiko Nakagawa, Nobukazu Fujimoto, et al.. (2021). Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study. The Lancet Respiratory Medicine. 9(6). 613–621. 55 indexed citations

Cheng, Yuen Yee, Emma M. Rath, Ling Zhuang, et al.. (2020). CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence In Situ Hybridisation. Frontiers in Oncology. 10. 579327–579327. 14 indexed citations

Ahmadzada, Tamkin, Kenneth Lee, Candice Clarke, et al.. (2019). High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes. Lung Cancer. 130. 35–41. 17 indexed citations

10.

Blinman, Prunella, et al.. (2018). Understanding Immune Tolerance of Cancer: Re‐Purposing Insights from Fetal Allografts and Microbes. BioEssays. 40(8). e1800050–e1800050. 7 indexed citations

11.

Kao, Steven, Brian C. McCaughan, Takashi Nakano, et al.. (2018). Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery. Journal of Thoracic Oncology. 14(2). 288–293. 10 indexed citations

12.

Zielinski, Robert, et al.. (2017). Pseudoprogression Associated with Clinical Deterioration and Worsening Quality of Life in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 13(1). e1–e2. 5 indexed citations

13.

Kao, Steven, Yuen Yee Cheng, Marissa Williams, et al.. (2017). Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 12(9). 1421–1433. 119 indexed citations

14.

Kao, Steven, Ashkaun Shaterian, David M. Cauvi, et al.. (2014). Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor geneECRG4in lung. Experimental Lung Research. 41(3). 162–172. 9 indexed citations

15.

Kirschner, Michaela B., et al.. (2013). Hemolysis and its impact on cell-free microRNA biomarkers. Frontiers in Genetics. 4. 3 indexed citations

16.

Shaterian, Ashkaun, Steven Kao, Lin Chen, et al.. (2012). The candidate tumor suppressor gene Ecrg4 as a wound terminating factor in cutaneous injury. Archives of Dermatological Research. 305(2). 141–149. 24 indexed citations

17.

Kirschner, Michaela B., Yuen Yee Cheng, Steven Kao, et al.. (2012). Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 7(7). 1184–1191. 94 indexed citations

18.

Kao, Steven, Kim Griggs, Kenneth Lee, et al.. (2011). Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology. 43(4). 313–317. 17 indexed citations

19.

Kao, Steven, et al.. (2010). A Pathological Complete Response in Malignant Pleural Mesothelioma after Combination Chemotherapy with Carboplatin and Pemetrexed. Journal of Thoracic Oncology. 5(3). 405–406. 1 indexed citations

20.

Kao, Steven, Kate Mahon, Betty Lin, et al.. (2009). Pleural Well-Differentiated Papillary Mesothelioma: A Case Report. Journal of Thoracic Oncology. 4(7). 920–922. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact